↓ Skip to main content

Eculizumab hepatotoxicity in pediatric aHUS

Overview of attention for article published in Pediatric Nephrology, November 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

policy
1 policy source
twitter
5 X users

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
61 Mendeley
Title
Eculizumab hepatotoxicity in pediatric aHUS
Published in
Pediatric Nephrology, November 2014
DOI 10.1007/s00467-014-2990-5
Pubmed ID
Authors

Wesley Hayes, Sibylle Tschumi, Simon C. Ling, Janusz Feber, Michael Kirschfink, Christoph Licht

Abstract

Eculizumab is a humanized anti-C5 antibody approved for the treatment of atypical hemolytic uremic syndrome (aHUS). Its use is increasing in children following reports of its safety and efficacy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 2%
Czechia 1 2%
Unknown 59 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 18%
Researcher 9 15%
Student > Ph. D. Student 7 11%
Student > Bachelor 6 10%
Other 6 10%
Other 13 21%
Unknown 9 15%
Readers by discipline Count As %
Medicine and Dentistry 31 51%
Biochemistry, Genetics and Molecular Biology 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Agricultural and Biological Sciences 3 5%
Nursing and Health Professions 2 3%
Other 4 7%
Unknown 9 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2021.
All research outputs
#5,875,823
of 22,771,140 outputs
Outputs from Pediatric Nephrology
#1,002
of 3,535 outputs
Outputs of similar age
#80,386
of 361,557 outputs
Outputs of similar age from Pediatric Nephrology
#7
of 49 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,535 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,557 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.